Skip to main content

Animations

MJFF Publications

2061 - 2070 of 8715 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0676
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4222
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1166
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.3265
    Citation Count: 30
  • Summary Details
    RESTRICTED
    Title: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Olfactory Dysfunction and Long-Term Trajectories of Sleep Disorders among early Parkinson’s Disease: Findings from a Longitudinal Cohort
    Journal Name: Neuroepidemiology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000539330
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.